Thrombophilic status may predict prognosis in patients with metastatic BRAFV600-mutated melanoma who are receiving BRAF inhibitors

J Am Acad Dermatol. 2016 Jun;74(6):1254-1256.e4. doi: 10.1016/j.jaad.2015.11.006.

¹ Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy.
² Division of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy.
³ Unit of Medical Oncology, Hospital Papa Giovanni XXIII, Bergamo, Italy.
⁴ Department of Oncology, Clinical Research Laboratory, IRCCS - Istituto di Ricerche Farmacologiche "Mario Negri," Milan, Italy.
⁵ Unit of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy.
⁶ Division of Pathological Anatomy, Hospital Papa Giovanni XXIII, Bergamo, Italy.
⁷ Unit of Medical Oncology, Hospital Papa Giovanni XXIII, Bergamo, Italy. Electronic address: mariomandala@tin.it.

No abstract available

Publication types